ATE245661T1 - Natürliche menschliche igm antikörper - Google Patents

Natürliche menschliche igm antikörper

Info

Publication number
ATE245661T1
ATE245661T1 AT93910791T AT93910791T ATE245661T1 AT E245661 T1 ATE245661 T1 AT E245661T1 AT 93910791 T AT93910791 T AT 93910791T AT 93910791 T AT93910791 T AT 93910791T AT E245661 T1 ATE245661 T1 AT E245661T1
Authority
AT
Austria
Prior art keywords
igm antibodies
natural human
human igm
human
antibodies
Prior art date
Application number
AT93910791T
Other languages
English (en)
Inventor
Toby C Rodman
Original Assignee
Inst Human Genetics Biochem
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Inst Human Genetics Biochem filed Critical Inst Human Genetics Biochem
Application granted granted Critical
Publication of ATE245661T1 publication Critical patent/ATE245661T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10—RNA viruses
    • C07K16/112—Retroviridae (F), e.g. leukemia viruses
    • C07K16/114—Lentivirus (G), e.g. human immunodeficiency virus [HIV], feline immunodeficiency virus [FIV] or simian immunodeficiency virus [SIV]
    • C07K16/1147—Regulatory proteins, e.g. trans-activator of transcription [TAT], rev or vacuolar protein targeting [VPT]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Virology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AT93910791T 1992-04-24 1993-04-26 Natürliche menschliche igm antikörper ATE245661T1 (de)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US87391792A 1992-04-24 1992-04-24
US91202692A 1992-07-09 1992-07-09
US92441292A 1992-07-30 1992-07-30
PCT/US1993/003884 WO1993022349A1 (en) 1992-04-24 1993-04-26 NATURAL HUMAN IgM ANTIBODIES

Publications (1)

Publication Number Publication Date
ATE245661T1 true ATE245661T1 (de) 2003-08-15

Family

ID=27420479

Family Applications (1)

Application Number Title Priority Date Filing Date
AT93910791T ATE245661T1 (de) 1992-04-24 1993-04-26 Natürliche menschliche igm antikörper

Country Status (7)

Country Link
EP (1) EP0648226B1 (de)
KR (2) KR100310413B1 (de)
AT (1) ATE245661T1 (de)
AU (1) AU674314B2 (de)
CA (1) CA2134080C (de)
DE (1) DE69333111T2 (de)
WO (1) WO1993022349A1 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2731355B1 (fr) * 1995-03-08 1997-05-30 Neovacs Nouveaux immunogenes, nouveaux anticorps, procede de preparation et compositions pharmaceutiques les renfermant
WO1996027389A1 (fr) * 1995-03-08 1996-09-12 Neovacs Immunogenes denues de toxicite derivant d'une proteine de regulation retrovirale, anticorps, procede de preparation et compositions pharmaceutiques les renfermant
US6200575B1 (en) 1996-03-07 2001-03-13 Neovacs Non-toxic immunogens derived from a retroviral regulatory protein antibodies preparation process and pharmaceutical compositions comprising them
WO1998056719A2 (en) * 1997-06-13 1998-12-17 Medical Analysis Inc. Control standards for clinical chemistry assays
US6610833B1 (en) * 1997-11-24 2003-08-26 The Institute For Human Genetics And Biochemistry Monoclonal human natural antibodies
AU4082300A (en) * 1999-06-21 2001-01-09 Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The Hiv tat peptides and multiple peptide conjugate system

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1340982C (en) * 1988-03-25 2000-05-02 Toby C. Rodman Protamine-reactive igm antibodies
JPH06502723A (ja) * 1990-11-09 1994-03-24 ヴェリジェン，インコーポレーテッド 抗体を検出する分析系の感度及び／又は特異性の決定方法

Also Published As

Publication number Publication date
DE69333111T2 (de) 2004-04-22
WO1993022349A1 (en) 1993-11-11
KR100310413B1 (ko) 2002-02-28
DE69333111D1 (de) 2003-08-28
EP0648226B1 (de) 2003-07-23
AU4116093A (en) 1993-11-29
CA2134080C (en) 2004-07-13
AU674314B2 (en) 1996-12-19
KR100315596B1 (ko) 2002-01-15
EP0648226A1 (de) 1995-04-19
CA2134080A1 (en) 1993-11-11

Similar Documents

Publication Publication Date Title
DK0700445T3 (da) Stressproteiner og anvendelser deraf
DE69222303D1 (de) Kationisierte antikörper gegen intrazelluläre eiweisse
DK0759944T3 (da) Forbedringer af og relateret til peptidfremføring
PT90574A (pt) Processo de preparacao de polipeptidos e de determinacao da presenca de anticorpos de proteina latente anti-virus do papiloma
NO980915D0 (no) Rekombinante anti-CD4-antistoff egnet for human terapi
DE69228701D1 (de) Fragmente von Prion Proteinen.
TR199900666T2 (xx) �nsan paratormonu ile ilgili peptidlere kar�� antikor.
PL400308A1 (pl) Terapia immunizacyjna w oparciu o peptydy do leczenia miazdzycy oraz w oparciu o peptydy do okreslania odpowiedzi odpornosci przeciwko utlenionym lipoproteinom o niskiej gestosci
EP1266965A3 (de) Rekombinante Antikörper zur humanen Therapie
ATE255906T1 (de) Antikörper gegen cd40
DE68917323D1 (de) Expressions-Vektor für Fusions-Proteine und Immunogen-Proteine.
DE68925226D1 (de) Monoklonale Antikörper
DK0523395T3 (da) Seroreaktive områder på proteinerne E1 og E2 i HPV 16
NO973875D0 (no) Fremgangsmåte for simulering av en immunrespons
ATE245661T1 (de) Natürliche menschliche igm antikörper
ATE382696T1 (de) Immunoreaktive antigene des hepatitis e viruses
ATE435034T1 (de) Expression und charakterisierung eines hiv-1 hüllproteins, das mit einer breitreaktiven neutralisierenden antikörperantwort assoziiert ist.
TR199801769T2 (xx) D���k reg�lasyona diren�li C3 d�n��t�r�c�ler.
MY131433A (en) Novel metazoan parasite antigens having pepstatin binding activity and their use in vaccines
DK513687D0 (da) Monoklonale antistoffer over for ifn-omega, fremgangsmaade til deres fremstilling og deres anvendelse til rensning samt paavisning af ifn-omega
NO883603L (no) Humane monoklonale antistoffer og profylaktiske og terapeutiske midler mot infektioese sykdommer inneholdende disse som effektiv bestanddel.
DE3687542D1 (de) Monoklonaler antikoerper gegen humanes protein c.
DK0513565T3 (da) Monoklonale antistoffer mod plasmin-antiplasmin-komplekset, fremgangsmåde til deres fremstilling og deres anvendelse
ES2067501T3 (es) Antigeno recombinante de treponema hyodysenteriae y sus usos.
DE69333683D1 (de) Antikörper-testbesteck zur bestimmung von amylin

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties